LEADER 00940nas 2200337 450 001 990003484500203316 005 20110126170014.0 011 $a0930-7516 035 $a000348450 035 $aUSA01000348450 035 $a(ALEPH)000348450USA01 035 $a000348450 100 $a20110117a----9999km-y-itay50------ba 101 0 $aeng 102 $aDE 110 $aafazz--|||| 200 1 $aChemical engineering and technology 210 $aWeinheim$cVCH 215 $av.$cill.$d28 cm 300 $aComincia nel 1987 300 $aDescrizione basata su n.1(1999)- 606 0 $aChimica applicata$xPeriodici$2BNCF 676 $a660.5 801 0$aIT$bsalbc$gISBD 912 $a990003484500203316 958 $aSCI$bPER I$c1999-$l1999; 959 $aSE 979 $aCIANATIEMP$b90$c20110117$lUSA01$h1528 979 $aCIANATIEMP$b90$c20110126$lUSA01$h1700 996 $aChemical engineering and technology$9796701 997 $aUNISA LEADER 02724nam 22006974a 450 001 9910458855103321 005 20200520144314.0 010 $a0-8018-8887-5 035 $a(CKB)2560000000048260 035 $a(OCoLC)232160418 035 $a(CaPaEBR)ebrary10188452 035 $a(SSID)ssj0000200604 035 $a(PQKBManifestationID)12056248 035 $a(PQKBTitleCode)TC0000200604 035 $a(PQKBWorkID)10220547 035 $a(PQKB)10224586 035 $a(SSID)ssj0000474875 035 $a(PQKBManifestationID)11335791 035 $a(PQKBTitleCode)TC0000474875 035 $a(PQKBWorkID)10462814 035 $a(PQKB)10743769 035 $a(MiAaPQ)EBC3318253 035 $a(OCoLC)190703535 035 $a(MdBmJHUP)muse2524 035 $a(Au-PeEL)EBL3318253 035 $a(CaPaEBR)ebr10188452 035 $a(OCoLC)923192345 035 $a(EXLCZ)992560000000048260 100 $a20060328d2006 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aMedicare prospective payment and the shaping of U.S. health care$b[electronic resource] /$fRick Mayes and Robert A. Berenson 210 $aBaltimore $cJohns Hopkins University Press$d2006 215 $a1 online resource (264 p.) 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a0-8018-8454-3 311 $a0-8018-8855-7 320 $aIncludes bibliographical references (p. [211]-235) and index. 327 $aOrigins and policy gestation -- Development, growing appeal, and passage of prospective payment -- The phase-in years and beginning of "rough justice" for hospitals -- Medicare policy's subordination to budget policy, increased hospital cost shifting, and the rise of managed care -- The resource-based relative-value scale reforms for physician payment -- The calm before the storm -- The reckoning and reversal -- Conclusion : how medicare does and should shape U.S. health care. 606 $aMedicare 606 $aMedicare$xClaims administration$zUnited States 606 $aMedical care, Cost of$zUnited States 606 $aHospitals$xProspective payment$zUnited States 608 $aElectronic books. 615 0$aMedicare. 615 0$aMedicare$xClaims administration 615 0$aMedical care, Cost of 615 0$aHospitals$xProspective payment 676 $a368.4/2600973 700 $aMayes$b Rick$f1969-$0981651 701 $aBerenson$b Robert A$0981652 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910458855103321 996 $aMedicare prospective payment and the shaping of U.S. health care$92240424 997 $aUNINA LEADER 02102nam 22004693u 450 001 9910780709803321 005 20230721024643.0 010 $a1-299-38764-0 035 $a(CKB)2520000000000333 035 $a(EBL)1157674 035 $a(OCoLC)833767829 035 $a(MiAaPQ)EBC1157674 035 $a(EXLCZ)992520000000000333 100 $a20130418d2008|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 200 10$aCompetence Building and Leveraging in Interorganizational Relations$b[electronic resource] 210 $aBradford $cEmerald Group Publishing Limited$d2008 215 $a1 online resource (215 p.) 225 1 $aAdvances in Applied Business Strategy ;$vv.11 300 $aDescription based upon print version of record. 311 $a1-84950-521-7 311 $a0-7623-1466-4 330 $aThe competence-based perspective on strategy and management offers an integrative approach to strategy and management theory, research, and practice. Nearly two decades of research, theory development, and application have demonstrated the theoretical coherence, researchability, and practicability of a fundamental focus on organizational competences. The competence-based perspective is now providing a productive broad church for advancing theory development, research, and practice in both strategic and general management.In the twenty-first century, network-based strategies and processes are b 410 0$aAdvances in Applied Business Strategy 606 $aInternational relations 606 $aInterorganizational relations 606 $aOrganizational learning 615 4$aInternational relations. 615 4$aInterorganizational relations. 615 4$aOrganizational learning. 676 $a658.4 700 $aMartens$b Rudy$01583488 701 $aHeene$b Aime$0340482 701 $aSanchez$b Ron$0330828 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a9910780709803321 996 $aCompetence Building and Leveraging in Interorganizational Relations$93866630 997 $aUNINA LEADER 05142nam 22016573a 450 001 9910346843303321 005 20250203235431.0 010 $a9783038970668 010 $a3038970662 024 8 $a10.3390/books978-3-03897-066-8 035 $a(CKB)4920000000095207 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/58295 035 $a(ScCtBLL)7724aed1-8acc-447b-a70d-a7226fbf8ce8 035 $a(OCoLC)1117885981 035 $a(oapen)doab58295 035 $a(EXLCZ)994920000000095207 100 $a20250203i20192019 uu 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aResearch of Pathogenesis and Novel Therapeutics in Arthritis$fChih-Hsin Tang 210 $cMDPI - Multidisciplinary Digital Publishing Institute$d2019 210 1$aBasel, Switzerland :$cMDPI,$d2019. 215 $a1 electronic resource (366 p.) 311 08$a9783038970651 311 08$a3038970654 330 $aArthritis has a high prevalence globally and includes over 100 different types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for arthritis patients. This book summarizes and discusses the global picture of the current understanding of arthritis. 606 $aMedicine and Nursing$2bicssc 610 $areceptor activator of nuclear factor ?B 610 $ainfliximab 610 $atripterine 610 $atriptolide 610 $aosteoblast 610 $atumor necrosis factor-alpha 610 $asynovial cell 610 $aanti-arthritis 610 $abiosimilars 610 $aEpstein-Barr virus 610 $acytokines 610 $aSOX9 610 $aparathyroid hormone 610 $anitric oxide 610 $arat 610 $aetanercept 610 $aangiogenesis 610 $aglycosylation 610 $amitogen activated protein kinase 610 $aTh9 lymphocytes 610 $arheumatoid arthritis 610 $aIL-6 610 $aclodronate 610 $abone erosion 610 $amesenchymal stem cells 610 $acollagen-induced arthritis 610 $abiological 610 $agene expression 610 $ainflammatory arthritis 610 $aosteoarthritis 610 $afraxinellone 610 $anuclear factor kappa B 610 $amessenger RNA 610 $ainflammation 610 $amiRNA 610 $adisease-modifying 610 $aadipokines 610 $aWNT 610 $aglycoprotein 42 610 $amiR-199a-5p 610 $aproliferation 610 $anext-generation sequencing 610 $acollagen 610 $aosteoarthritis (OA) 610 $aexperimental arthritis 610 $abone morphogenetic protein 610 $aTNF-? 610 $acomputational modeling 610 $abasic research 610 $aosteoclast 610 $atherapeutics 610 $acertolizumab pegol 610 $achondrocytes 610 $aprogenitor cells 610 $aadjuvant arthritis 610 $aadalimumab 610 $atriterpenoid 610 $asclareol 610 $aTNF? 610 $afibroblast growth factor 2 610 $aantibodies 610 $aosteoblasts 610 $amolecular pathology 610 $aTh17 610 $aimmunology 610 $aobesity 610 $avisfatin 610 $aarticular cartilage 610 $aautoimmune 610 $abiomarkers 610 $acelastrol 610 $aMAPK 610 $adisease pathways 610 $aIL1? 610 $aarthritis 610 $abioinformatics 610 $aanticitrullinated peptide antibodies 610 $adrug delivery system 610 $aantagonists 610 $ashared epitope 610 $apathology 610 $aSMA- and MAD-related protein 610 $asmall-molecule inhibitor 610 $atransforming growth factor ? 610 $amice 610 $agolimumab 610 $aspinal fusion 610 $aantirheumatic drug 610 $aearly osteoarthritis 610 $astem cell 610 $arheumatoid factor 610 $atherapeutic antibody 610 $abisphosphonate 610 $aosteoclastogenesis 610 $ainterleukin 610 $aspondyloarthropathies 610 $aclinical translation 610 $atherapy 610 $aTraditional Chinese medicine 610 $achemokines 610 $astructure 610 $acell signaling 610 $amicroRNA 615 7$aMedicine and Nursing 700 $aTang$b Chih-Hsin$01305960 801 0$bScCtBLL 801 1$bScCtBLL 906 $aBOOK 912 $a9910346843303321 996 $aResearch of Pathogenesis and Novel Therapeutics in Arthritis$93028066 997 $aUNINA